David Hallal, CEO at ALEXION PHARMACEUTICALS INC (ALXN), sold 332 shares at $137.14 ($46K) on 2016-08-08, disclosed to the SEC on 2016-08-10.
Seasonal sale ($46k) by CEO — this insider has traded ALXN in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ITOS | SELL | 2025-06-06 | $2.3M | — | Filing → |
| ALVR | SELL | 2022-10-21 | $5.1M | — | Filing → |
| ALVR | SELL | 2022-09-30 | $2.9M | — | Filing → |